Læknablaðið - 15.03.2003, Síða 34

FRÆÐIGREINAR / FJÖLÓMETTAÐAR FITUSÝRUR OG LÆKNINGAR
54. Eritsland J. Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of
dietary supplementation with n-3 fatty acids on coronary artery bypass graft
patency. Am J Cardiol 1996; 77: 31-6.
55. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing
restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch
Int Med 1993; 153:1595-601.
56. Bairati I, Roy L, Meyer F. Double-blind, randomized, controlled trial of fish
oil supplements in prevention of recurrence of stenosis after coronary
angioplasty. Circulation 1992; 85: 950-6.
57. Lcaf A, Jorgensen MB, Jacobs AK, Cote G, Schoenfeld DA, Scheer J, et al.
Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994;
90: 2248-57.
58. Johansen O, Brekke M, Seljeflot I. Abdelnoor M, Arnesen H. N-3 fatty acids
do not prevent restenosis after coronary angioplasty: results from the CART
study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999; 33:
1619-26.
59. Olszewski AJ, McCully KS. Fish oil decreases serum homocysteine in hyper-
lipemic men. Coron Artery Dis 1993; 4:53-60.
60. Hsu HC, Lee YT, Chen MF. Effect of n-3 fatty acids on the composition and
binding properties of lipoproteins in hypertriglyceridemic patients. Am J Clin
Nutr 2000;71:28-35.
61. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:
115-26.
62. Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Preston FE. The effects
of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane
phospholipids, erythrocyte deformability and blood viscosity in healthy
volunteers. Atherosclerosis 1985; 55: 267-81.
63. Leaf A, Kang JX, Xiao YF, Billman GE. Dietary n-3 fatty acids in the preven-
tion of cardiac arrhythmias. Curr Op Clin Nutr Metabol Care 1998; 1: 225-8.
64. Li Y, Kang JX, Leaf A. Differential effects of various eicosanoids on the
production or prevention of arrhythmias in cultured neonatal rat cardiac
myocytes. Prostaglandins 1997; 54:511-30.
65. Ðillman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary
pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999; 99:2452-7.
66. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Comparative
efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular
fibrillation threshold in marmoset monkeys. Am J Clin Nutr 1993; 58:666-9.
67. McLennan PL, Abeywardena MY, Charnock JS. Dietary fish oil prevents
ventricular fibrillation following coronary artery occlusion and reperfusion.
Am HeartJ 1988; 116: 709-17.
68. Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effects of dietary fish oil on
ventricular premature complexes. Am J Cardiol 1995; 76: 974-7.
69. Hardarson T, Kristinsson A, Skuladottir G, Asvaldsdottir H, Snorrason SP.
Cod liver oil does not reduce ventricular extrasystoles after myocardial infarc-
tion.JInt Mcd 1989; 226: 33-7.
70. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J,
et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsatura-
ted fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274:1363-7.
71. Rossi E, Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarri-
age associated with antiphospholipid antibodies (APL): a pilot study. Lupus
1993; 2:319-23.
72. DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in
patients with Raynaud's phenomenon: a double-blind, controlled, prospective
study. Am J Med 1989; 86:158-64.
73. Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, et al.
Report of the Canadian Hypertension Society Consensus Conference: 2.
Nonpharmacologic management and prevention of hypertensive disorders in
pregnancy. CMAJ 1997; 157:907-19.
74. Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil on early
delivery and pre-eclampsia: indications from a 50-year-old controlled trial.
Brit J Nutr 1990; 64: 599-609.
75. Rylance PB, Gordge MP, Saynor R, Parsons V, Weston MJ. Fish oil modifies
lipids and reduces platelet aggregability in haemodialysis patients. Nephron
1986; 43:196-202.
76. Shapiro JA, Koepsell TD, Voigt LF, Dugowson CE, Kestin M, Nelson JL. Diet
and rheumatoid arthritis in women: a possible protective effect of fish
consumption. Epidemiol 1996; 7:256-63.
77. Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomcw LE, Bigaouette J,
ct al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A
double-blinded, controlled, crossover study. Ann Int Mcd 1987; 106:497-503.
78. van der Tempel H, Tulleken JE, Limburg PC, Muskiet FA, van Rijswijk MH.
Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis
1990; 49: 76-80.
79. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-
3 fatty acid supplementation in active rheumatoid arthritis. A 12-month,
double-blind, controlled study. Arthritis Rheum 1994; 37:824-9.
80. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B. Effect of six
months of fish oil supplementation in stable rheumatoid arthritis. A double-
blind, controlled study. Scand J Rheumatol 1992; 21:178-85.
81. Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, et al.
Effects of high-dose fish oil on rheumatoid arthritis after stopping nonstero-
idal antiinflammatory drugs. Clinical and immunc correlates. Arthritis Rheum
1995;38:1107-14.
82. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in
the treatment of rheumatoid arthritis. J Rheumatol 2000; 27: 2343-6.
83. Lau CS, Morley KD, Belch JJ. Effects of fish oil supplementation on non-stero-
idal anti-inflammatory drug requirement in patients with mild rheumatoid arth-
ritis-a double-blind placebo controlled study. Brit J Rheumatol 1993; 32:982-9.
84. Belch JJ, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering
dietary essential fatty acids on requirements for non-steroidal anti-inflamma-
tory drugs in patients with rheumatoid arthritis: a doublc blind placebo con-
trolled study. Ann Rheumat Dis 1988; 47: 96-104.
85. Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew
LE, et al. Dietary fish oil and olive oil supplementation in patients with
rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990;
33:810-20.
86. Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ,
Holmes GK, et al. Treatment of ulcerative colitis with fish oil supplementa-
tion: a prospective 12 month randomised controlled trial. Gut 1992; 33: 922-8.
87. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K,
Gramlich TL, et al. Dietary supplementation with fish oil in ulcerative colitis.
Ann Int Med 1992; 116:609-14.
88. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active
ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J
Gastroenterol 1992; 87:432-7.
89. Dichi I, Frenhane P, Dichi JB, Correa CR, Angeleli AY, Bicudo MH, et al.
Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis.
Nutrition 2000; 16:87-90.
90. Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for
asthma. (update of Cochrane Database Syst Rev 2000; (2): CD001283.]
Cochrane Database of Systematic Reviews [computer file.] 2000; CD001283.
91. Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woolcock AJ. Con-
sumption of oily fish and childhood asthma risk. Med J Austral 1996; 164:137-
40.
92. Smit HA, Grievink L, Tabak C. Dietary influences on chronic obstructive
lung disease and asthma: a review of the epidemiological evidence. Proc Nutr
Soc 1999; 58: 309-19.
93. Shahar E, Boland LL, Folsom AR, Tockman MS, McGovern PG, Eckfeldt
JH. Docosahexaenoic acid and smoking-related chronic obstructive pulmo-
nary disease. The Atherosclerosis Risk in Communities Study Investigators.
Am J Resp Crit Carc Med 1999; 159:1780-5.
94. Blok WL. Vogels MT, Curfs JH, Eling WM, Buurman WA, van der Meer JW.
Dietary fish-oil supplementation in experimental gram-negative infection
and in cerebral malaria in mice. J Infect Dis 1992; 165: 898-903.
95. Björnsson S, Harðardóttir 1, Gunnarsson E, Haraldsson A. Dietary fish oil
supplementation increases survival in mice following Klebsiella pneumoniae
infection. Scand J Infect Dis 1997; 29:491-3.
96. Þórisdóttir A, Sigurðsson JR, Erlendsdóttir H, Einarsson I, Gudmundsson S,
Gunnarsson E, et al. Áhrif lýsisneyslu á bakteríuvöxt in vivo. Læknablaðiö
2001;87:715-8.
97. Chyi A, Yeh SL. Effects of dietary fish oil on survival rate, plasma amino acid
pattern, and inflammatory-related mediators in diabetic rats with sepsis. Clin
Nutr 2000; 19: 313-8.
98. Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, et al.
Early enteral administration of a formula (Impact) supplemented with argi-
nine, nucleotides, and fish oil in intensive care unit patients: results of a multi-
center, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-49.
99. Kudsk KA, Minard G, Croce MA, Brown RO, Lowrey TS, Pritchard FE, et
al. A randomized trial of isonitrogenous enteral diets after severe trauma. An
immune-enhancing diet reduces septic complications. Ann Surg 1996; 224:
531-40.
100. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson
TE, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-
linolenic acid, and antioxidants in patients with acute respiratory distress
syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27:
1409-20.
101. Galban C, Montejo JC, Mesejo A, Marco P, Celaya S, Sanchez-Segura JM, et
al. An immune-enhancing enteral diet reduces mortality rate and episodes of
bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28:643-
8.
102. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a
systematic review of clinical outcome. Crit Care Med 1999; 27:2799-805.
103. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should
immunonutrition become routine in critically ill patients? A systematic
review of the evidence. JAMA 2001; 286:944-53.
104. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with
omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in
adolescents. Am J Obstetr Gynecol 1996; 174:1335-8.
105. Donadio JV Jr. Omega-3 polyunsaturated fatty acids. a potential new
treatment of immune renal disease. Mayo Clin Proc 1991; 66:1018-28.
106. Rekola S. Bergstrand A. Bucht H. Deterioration of GFR in IgA nephropathy
as measured by 51Cr-EDTA clearance. Kidney Int 1991; 40:1050-4.
107. Hamazaki T, Tateno S, Shishido H. Eicosapentaenoic acid and IgA nephro-
pathy. Lancet 1984; i: 1017-28.
108. Bennett WM, Walker RG, Kincaid-Smith P. Treatment of IgA nephropathy
with eicosapentaenoic acid (EPA): a two-year prospective trial. Clin Nephrol
1989; 31:128-31.
109. Pettersson EE, Rekola S, Berglund L, Sundqvist KG, Angelin B, Diczfalusy U,
et al. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids:
a prospective, double-blind, randomized study. Clin Nephrol 1994; 41:183-90.
110. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE, for the
Mayo Nephrology Collaborative Group. A controlled trial of fish oil in IgA
nephropathy. N Engl J Med 1994; 331:1194-9.
111. Donadio JV Jr., Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC.
The long-term outcome of patients with IgA nephropathy treated with fish oil
in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc
Nephrol 1999; 10:1772-7.
112. Donadio JV Jr.. Larson TS, Bergstralh EJ, Grande JP. A randomized trial of
high-dose compared with low-dose omega-3 fatty acids in severe IgA nephro-
pathy. J Am Soc Nephrol 2001; 12: 791-9.
113. Cheng IK, Chan PC, Chan MK. The effect of fish-oil dietary supplement on
the progression of mesangial IgA glomerulonephritis. Nephrol Dial Trans-
plant 1990; 5: 241-6.
114. Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy varia-
bility. J Am Soc Nephrol 1997; 8:1739-44.
115. Hogg RJ. A randomized, placebo-controlled, multicenter trial evaluating
alternative-day prednisone and fish oil supplements in young patients with
IgA nephropathy. Am J Kidney Dis 1995; 26:792-6.
116. Thakkar RR, Wang OL, Zerouga M, Stillwell W, Haq A, Kissling R, et al.
Docosahexaenoic acid reverses cyclosporin A-induced changes in membrane
structure and function. Biochim Biophys Acta 2000; 1474:183-95.
117. Badalamenti S, Salerno F, Lorenzano E, Paone G, Como G, Finazzi S, et al.
Renal effects of dictary supplementation with fish oil in cyclosporine-treated
liver transplant recipients. Hepatol 1995; 22:1695-71.
118. Homan van der Heide JJ, Bilo HJ, Tegzess AM, Donker AJ. The effects of
dietary supplementation with fish oil on renal function in cyclosporine-
treated rcnal transplant recipients. Transplantation 1990; 49: 523-7.
119. Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F. Results of a 1-
year randomized controlled trial with omega-3 fatty acid fish oil in renal
transplantation under triple immunosuppressive therapy. Transplant Proc
1995; 27:846-9.
120. Hanson JM, Hoy CE, Standgaard S. Fish oil and cyclosporin A-induced renal
hypoperfusion in kidney-transplanted patients. Nephrol Dial Transpl 1995;
10:1745-50.
Læknablaðið 2003/89